Ketamine eases bipolar depression in new RCT

A new randomized controlled trial (RCT) found IV ketamine significantly reduced depressive symptoms in people with treatment-resistant bipolar depression, compared to a placebo. The University of Toronto study with Diana K. Orsini, MSc, MPH, sheds light on its potential for a patient group often excluded from prior psychedelic research.